Fact CheckerSign in

NCT07782788Not yet recruiting

Predictors of Cardiac Arrhythmia in Rheumatoid Arthritis Patients

Evaluation of QT Dispersion , P Wave Dispersion and Tp-e Dispersion as Predictors of Cardiac Arrhythmia in Rheumatoid Arthritis Patients

Source: ClinicalTrials.gov · Last updated 24 Aug 2026

Brief summary (registry, in English)

To evaluate QT dispersion, P-wave dispersion and Tp-e dispersion as predictors of cardiac arrhythmias in patients with rheumatoid arthritis and to assess their relationship with disease characteristics and inflammatory activity

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
120 (estimated)
First submitted
20 Aug 2026
Start date
1 Oct 2026
Primary completion date
1 Oct 2027
Lead sponsor
Assiut University
NCT number
NCT07782788

What you commit to

  • Study type: Observational
  • Planned participants: 120
  • From 1 Oct 2026 to the primary completion date, 1 Oct 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of other autoimmune diseases
  • Thyroid disorders
  • Use of medications affecting cardiac conduction or repolarization such as amiodarone and other antiarrhythmic drugs
  • Known cardiac diseases including ischemic heart disease, valvular heart disease, cardiomyopathy, heart failure or congenital heart disease

Other

  • Electrolyte disturbances including hypocalcemia, hypokalemia and hypomagnesemia

Who the study is looking for

  • Patients diagnosed with rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria
  • Age ≥18 years
  • Male and female patients

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.